Bcl-2 over-expression reduces growth rate and prolongs G1 phase in continuous chemostat cultures of hybridoma cells.

Recent studies have suggested that Bcl-2 can affect cell cycle re-entry by inhibiting the transition from G0/G1 to S phase. In this study, we have taken a novel route to the study of the relationship between Bcl-2 expression and cell cycle progression. Continuous cultures of pEF (control) and Bcl-2 transfected murine hybridoma cells were operated at a range of dilution rates from 0.8 day-1 down to 0.2 day-1. The specific growth rate of the pEF cell line was the same as the dilution rate down to a value of 0.6 day-1. However, as the dilution rate was reduced stepwise to 0.2 day-1, the growth rate levelled-off at approximately 0.55 day-1 and this coincided with a fall in culture viability. By contrast, the specific growth rate of the Bcl-2 transfected cell line followed the dilution rate down to a value of 0.3 day-1 with high levels of cell survival. At high dilution rates, the cell cycle distributions were very similar for both cell lines. However, the distributions diverged as the dilution rate was reduced and, at a rate of 0.2 day-1, the percentage of G1 cells in the Bcl-2 culture was 80%, compared to only 56% in the pEF cell population. This corresponded with a greater extension in the duration of the G1 phase in the Bcl-2 cells, which was 1.7 days at the lowest dilution rate tested, compared to only 0.6 day for the pEF cell line. The durations of the G2/M and S phases remained constant throughout the culture. The maximum doubling time was 1.2 days in the pEF culture compared to 2.3 days in the Bcl-2 culture. Analysis of amino acids, ammonia and lactate concentrations indicated that the observed effects on cell cycle dynamics were probably not due to differences in the culture environment. It is suggested that the expression of Bcl-2 can effect G1 to S phase transition in continuously cycling cells, but this is only apparent at suboptimal growth rates.

[1]  M. Al‐Rubeai,et al.  Apoptosis and bioprocess technology. , 1998, Advances in biochemical engineering/biotechnology.

[2]  W M Miller,et al.  Transient responses of hybridoma cells to nutrient additions in continuous culture: I. Glucose pulse and step changes , 1989, Biotechnology and bioengineering.

[3]  M. Al‐Rubeai,et al.  Death mechanisms of animal cells in conditions of intensive agitation , 1995, Biotechnology and bioengineering.

[4]  F Franĕk,et al.  Nucleosomes occurring in protein‐free hybridoma cell culture Evidence for programmed cell death , 1991, FEBS letters.

[5]  M Al-Rubeai,et al.  Prevention of hybridoma cell death by bcl-2 during suboptimal culture conditions. , 1997, Biotechnology and bioengineering.

[6]  M Al-Rubeai,et al.  In hybridoma cultures, deprivation of any single amino acid leads to apoptotic death, which is suppressed by the expression of the bcl-2 gene. , 1998, Biotechnology and bioengineering.

[7]  A. Strasser,et al.  The anti‐apoptosis function of Bcl‐2 can be genetically separated from its inhibitory effect on cell cycle entry , 1997, The EMBO journal.

[8]  M. Betenbaugh,et al.  Overcoming apoptosis: new methods for improving protein-expression systems. , 1998, Trends in biotechnology.

[9]  J Tramper,et al.  A combined cell‐cycle and metabolic model for the growth of hybridoma cells in steady‐state continuous culture , 1995, Biotechnology and bioengineering.

[10]  M. Al‐Rubeai,et al.  Mechanisms and kinetics of monoclonal antibody synthesis and secretion in synchronous and asynchronous hybridoma cell cultures. , 1990, Journal of biotechnology.

[11]  G. Linette,et al.  Cross talk between cell death and cell cycle progression: BCL-2 regulates NFAT-mediated activation. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[12]  M. Al‐Rubeai,et al.  Cell death in bioreactors: A role for apoptosis , 1994, Biotechnology and bioengineering.

[13]  M. Collins,et al.  Growth factor starvation of bcl-2 overexpressing murine bone marrow cells induced refractoriness to IL-3 stimulation of proliferation. , 1994, Oncogene.

[14]  T G Cotter,et al.  Cell death (apoptosis) in cell culture systems. , 1995, Trends in biotechnology.

[15]  A. Levine,et al.  p53 and E2F-1 cooperate to mediate apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[16]  W. Kaelin,et al.  Deregulated transcription factor E2F-1 expression leads to S-phase entry and p53-mediated apoptosis. , 1994, Proceedings of the National Academy of Sciences of the United States of America.

[17]  J. M. Adams,et al.  Bcl-2 has a cell cycle inhibitory function separable from its enhancement of cell survival. , 1996, Oncogene.

[18]  A. Dickson,et al.  Apoptosis regulation and its applications to biotechnology. , 1998, Trends in biotechnology.

[19]  S. Mercille,et al.  Induction of apoptosis in nutrient‐deprived cultures of hybridoma and myeloma cells , 1994, Biotechnology and bioengineering.

[20]  H. Ueda,et al.  Overexpression of bcl‐2, apoptosis suppressing gene: Prolonged viable culture period of hybridoma and enhanced antibody production , 1995, Biotechnology and bioengineering.

[21]  K. Kinzler,et al.  Paradoxical inhibition of solid tumor cell growth by bcl2. , 1994, Cancer research.

[22]  Y. Tsujimoto,et al.  Involvement of the bcl-2 gene in human follicular lymphoma. , 1985, Science.

[23]  Gerard I. Evan,et al.  Induction of apoptosis in fibroblasts by c-myc protein , 1992, Cell.

[24]  S. Korsmeyer,et al.  bcl-2-Immunoglobulin transgenic mice demonstrate extended B cell survival and follicular lymphoproliferation , 1989, Cell.

[25]  A. Zantema,et al.  Cyclin D1 is an essential mediator of apoptotic neuronal cell death. , 1996, The EMBO journal.

[26]  David L. Vaux,et al.  Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells , 1988, Nature.

[27]  D. Murhammer,et al.  bcl-2 expression in Spodoptera Frugiperda Sf-9 and Trichoplusia Ni BTI-Tn-5B1-4 insect cells: effect on recombinant protein expression and cell viability. , 1997, Biotechnology and bioengineering.

[28]  M. Al‐Rubeai,et al.  Apoptosis in cell culture. , 1998, Current opinion in biotechnology.

[29]  A. Strasser,et al.  The cell death inhibitor Bcl‐2 and its homologues influence control of cell cycle entry. , 1996, The EMBO journal.